Malignant pleural mesothelioma has a poor prognosis with limited therapeutic options Although numerous trials have shown that combination immunotherapy with nivolumab and ipilimumab is one of the first line treatments for patients with unresectable MPM, there is limited data on delayed responses ove...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!